Metabolic syndrome treatment: focusing on acarbose
Aim. To compare the effectiveness of alpha-glucosidase inhibitor acarbose (150 or 300 mg/d) and non-pharmaceutical lifestyle modification in controlling arterial hypertension (AH), carbohydrate and lipid metabolism, and body weight (BW) among patients with impaired glucose tolerance (IGT) and AH.Mat...
| Published in: | Кардиоваскулярная терапия и профилактика |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2008-04-01
|
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1331 |